Illumina Inc (ILMN)

122.02
NASDAQ : Health Care
Prev Close 122.02
Day Low/High 0.00 / 0.00
52 Wk Low/High 119.37 / 196.47
Avg Volume 1.49M
Exchange NASDAQ
Shares Outstanding 146.90M
Market Cap 18.57B
EPS 3.20
P/E Ratio 42.42
Div & Yield N.A. (N.A)

Latest News

Illumina Launches IHope Program To Identify Causes Of Undiagnosed Genetic Diseases In Children

Illumina Launches IHope Program To Identify Causes Of Undiagnosed Genetic Diseases In Children

Illumina, Inc. (NASDAQ: ILMN) today announced the iHope program, a philanthropic initiative aimed at identifying the genetic causes of undiagnosed rare diseases in children.

Illumina To Webcast Live Presentation At The Citi Global Healthcare Conference

Illumina To Webcast Live Presentation At The Citi Global Healthcare Conference

Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the company's presentation at the Citi Global Healthcare Conference in New York, NY, on December 7, 2016.

Illumina Becomes #232 Most Shorted S&P 500 Component, Replacing Xylem

Illumina Becomes #232 Most Shorted S&P 500 Component, Replacing Xylem

The most recent short interest data has been released for the 10/31/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Illumina And Mayo Clinic Form Bioinformatics Relationship To Advance Genetic Disorder Testing

Illumina And Mayo Clinic Form Bioinformatics Relationship To Advance Genetic Disorder Testing

Illumina, Inc. (NASDAQ: ILMN) today announced it has entered an agreement with Mayo Clinic to make advancements in next-generation sequencing technology with the intent to accelerate Mayo's delivery of genetic and genomic...

Illumina Launches TruSight Tumor 170

Illumina Launches TruSight Tumor 170

Illumina, Inc. (NASDAQ:ILMN) today announced the launch of TruSight® Tumor 170, a 170 gene next-generation sequencing solution to support the transformation of the tumor-profiling paradigm from a series of...

Illumina Reports Full Financial Results For Third Quarter Of Fiscal Year 2016

Illumina Reports Full Financial Results For Third Quarter Of Fiscal Year 2016

Illumina, Inc. (NASDAQ:ILMN) today announced its full financial results for the third quarter of fiscal year 2016.

Week Ahead: Fed Meeting, Jobs Report Paint Clearer Picture for Rate Hike Chances

Week Ahead: Fed Meeting, Jobs Report Paint Clearer Picture for Rate Hike Chances

The Federal Reserve will again convene in the coming week to discuss monetary policy, but investors will instead focus on what it may mean for a rate hike in December.

Should You Sell Illumina Stock?

Should You Sell Illumina Stock?

Gene sequencer Illumina has shaken investors' faith with negative announcements this year.

German Court Issues Preliminary Injunction Against Amedes Fetalis® Test For Infringement Of Non-Invasive Prenatal Screening Patent

German Court Issues Preliminary Injunction Against Amedes Fetalis® Test For Infringement Of Non-Invasive Prenatal Screening Patent

Illumina, Inc. (NASDAQ: ILMN) and Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH), the world's leading healthcare diagnostics company, today announced that on October 5, 2016, the Düsseldorf...

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Illumina Inc. And Encourages Investors With Losses To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Illumina Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that it is investigating claims against Illumina Inc.

INVESTOR ALERT: Investigation Of Illumina Inc. Announced By Law Offices Of Howard G. Smith

INVESTOR ALERT: Investigation Of Illumina Inc. Announced By Law Offices Of Howard G. Smith

Law Offices of Howard G. Smith announces an investigation on behalf of investors of Illumina Inc.

Illumina Contributes To ClinVar Database

Illumina Contributes To ClinVar Database

Illumina, Inc. (NASDAQ: ILMN) announced today that it has contributed over 95,000 human genetic variants to ClinVar, a public database hosted by the National Center for Biotechnology Information (NCBI).

What IBM's Genomic Partnership With Quest Says About Thermo Fisher, Diagnostics Peers

What IBM's Genomic Partnership With Quest Says About Thermo Fisher, Diagnostics Peers

Quest and IBM are rolling out a genomic sequencing service powered by Big Blue's Watson supercomputer.

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

Technology stocks dominate the bearish ledger this week.

Trader's Daily Notebook: You Might Consider Selling Facebook

Trader's Daily Notebook: You Might Consider Selling Facebook

Do that if you like top ticking crowd favorites, but set a protective stop.

Avoid Twitter Like the Plague; It's Uninvestable

Avoid Twitter Like the Plague; It's Uninvestable

If Twitter puts up a dreadful quarter, shares will sell off again.

Fortinet Pre-Announces Lowered Guidance For 3Q Results

We’ll wait until we have more clarity on the issues that plagued the September quarter before considering entry points.

Adding to Our Telecom Position

We like AT&T's sticky and inelastic mobile business.

Jim Cramer's 'Mad Money' Recap: Here's Where Money Can Still Be Made

Jim Cramer's 'Mad Money' Recap: Here's Where Money Can Still Be Made

Don't focus on just one day of trading, Jim Cramer says.

Illumina Leads Healthcare Selloff, Abbott and Zimmer Also Fall

Illumina Leads Healthcare Selloff, Abbott and Zimmer Also Fall

Illumina fell 24% on news that it was cutting revenue guidance.

Weak Start to Earnings Season, Crude Slump Pull Wall Street Into Selloff

Weak Start to Earnings Season, Crude Slump Pull Wall Street Into Selloff

Wall Street sells off as a disappointing quarterly performance from Alcoa heralds a poor start to the third-quarter earnings season and crude oil retreats from highs.

Cramer: Sing It, Martha -- Nowhere to Run to in This Market, Nowhere to Hide

Cramer: Sing It, Martha -- Nowhere to Run to in This Market, Nowhere to Hide

On days like this, the money just keeps sloshing around.

Stocks at Three-Week Lows as Alcoa Heralds Poor Start to Earnings Season

Stocks at Three-Week Lows as Alcoa Heralds Poor Start to Earnings Season

Stock losses accelerate on Tuesday afternoon as a disappointing quarterly performance from Alcoa heralds a poor start to the third-quarter earnings season.

Midday Report: Yum! Brands Climbs on Franchise Plan; U.S. Stocks Slide

Midday Report: Yum! Brands Climbs on Franchise Plan; U.S. Stocks Slide

U.S. stocks slipped after a disappointing quarterly performance from Alcoa soured optimism over earnings season.

Illumina Shares Hammered by Sales Forecast Cut

Illumina Shares Hammered by Sales Forecast Cut

Cantor Fitzgerald says Illumina's outlook revision is not likely to affect industry peers.